Tiova Rotacap: Advanced COPD Symptom Control and Bronchodilation
| Product dosage: 18 mcg | |||
|---|---|---|---|
| Package (num) | Per cap | Price | Buy |
| 30 | $1.29 | $38.70 (0%) | 🛒 Add to cart |
| 60 | $1.12 | $77.40 $67.08 (13%) | 🛒 Add to cart |
| 90 | $0.82
Best per cap | $116.10 $73.96 (36%) | 🛒 Add to cart |
Synonyms | |||
Tiova Rotacap is a prescription medication formulated with Tiotropium Bromide, a long-acting muscarinic antagonist (LAMA) designed for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It works by relaxing the muscles around the airways in the lungs, making breathing easier. Delivered via a Rotahaler device, it provides consistent, 24-hour bronchodilation to help manage symptoms and improve lung function, representing a cornerstone in the long-term management strategy for COPD patients.
Features
- Contains Tiotropium Bromide Monohydrate equivalent to 18 mcg of Tiotropium.
- Administered via a dry powder inhaler system (Rotahaler).
- Delivers long-acting muscarinic antagonist (LAMA) therapy.
- Designed for oral inhalation only.
- Typically supplied in a blister pack of 10 capsules.
Benefits
- Provides sustained 24-hour bronchodilation, reducing the frequency of dosing and simplifying treatment regimens.
- Effectively reduces episodes of breathlessness (dyspnea) and wheezing, enhancing the ability to perform daily activities.
- Helps to decrease the number of COPD exacerbations, potentially reducing hospitalizations.
- Improves overall lung function as measured by spirometry (FEV1).
- Can lead to an enhanced quality of life by providing consistent symptom control throughout the day and night.
Common use
Tiova Rotacap is indicated for the long-term, once-daily maintenance treatment of bronchospasm associated with Chronic Obstructive Pulmonary Disease (COPD). It is not indicated for the initial treatment of acute bronchospasm. Its primary use is to control symptoms and improve lung function in patients with a confirmed diagnosis of COPD.
Dosage and direction
The recommended dosage is the inhalation of the contents of one Tiova Rotacap (18 mcg) once daily, at the same time each day, using the Rotahaler device. It is not to be taken more than once in a 24-hour period. The capsule must not be swallowed. Detailed steps for use are:
- Pull off the ribbed end of the Rotahaler transparent base.
- Place the Tiova Rotacap capsule upright in the square hole of the chamber.
- Push the transparent base back onto the mouthpiece until a click is heard.
- Hold the Rotahaler upright, exhale fully away from the mouthpiece, then place the mouthpiece in the mouth and close lips around it.
- Inhale deeply and steadily to pull the medication into your lungs.
- Hold your breath for up to 10 seconds, then exhale slowly.
- Open the Rotahaler to check if any powder remains; if so, repeat inhalation.
- Dispose of the empty capsule. Do not leave it in the chamber.
Precautions
- Inform your physician if you have a history of kidney problems, narrow-angle glaucoma, prostatic hyperplasia, or bladder neck obstruction.
- It may cause blurred vision or dizziness; exercise caution when driving or operating machinery.
- Immediate hypersensitivity reactions, including angioedema, may occur. Discontinue use and seek medical attention if such reactions develop.
- As an anticholinergic agent, it may worsen symptoms of urinary retention.
- Do not allow the powder to come into contact with your eyes, as it may cause pupil dilation and blurred vision or worsen narrow-angle glaucoma.
Contraindications
Tiova Rotacap is contraindicated in patients with a known hypersensitivity to tiotropium bromide, atropine or its derivatives, including ipratropium, or any component of the formulation.
Possible side effect
Common side effects may include:
- Dry mouth
- Constipation
- Upper respiratory tract infection
- Pharyngitis
- Sinusitis
- Non-specific chest pain
- Dyspepsia
- Urinary retention Less common but serious side effects require immediate medical attention and can include:
- Paradoxical bronchospasm (worsening of breathing immediately after inhalation)
- Worsening of narrow-angle glaucoma
- Worsening of urinary retention
- Signs of an allergic reaction (e.g., rash, hives, itching, swelling of the face, lips, tongue, or throat)
Drug interaction
- Concomitant use with other anticholinergic-containing drugs (e.g., ipratropium, aclidinium) may potentiate anticholinergic adverse effects and is not recommended.
- While no specific pharmacokinetic drug interactions are known, always inform your doctor of all other medications you are taking, including other inhaled medications, over-the-counter drugs, and herbal supplements.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. However, if it is almost time for the next scheduled dose, the missed dose should be skipped and the regular dosing schedule resumed. Do not take a double dose to make up for a missed one.
Overdose
An overdose is likely to manifest as excessive anticholinergic effects, such as severe dry mouth, visual disturbances, tachycardia, and difficulty in micturition. In case of suspected overdose, symptomatic and supportive therapy should be instituted. Medical attention should be sought immediately.
Storage
- Store at room temperature (15° - 30° C), protected from light and moisture.
- Keep the capsules in the blister pack until immediately before use.
- Keep out of reach of children and pets.
- Do not store the capsule inside the Rotahaler device.
- Do not puncture or break the capsule.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here.
Reviews
“After switching to Tiova Rotacap, my morning routine has become so much simpler. The once-daily dose is easy to remember, and I’ve noticed a significant reduction in my shortness of breath during my daily walks. It has genuinely improved my quality of life.” – Patient with moderate COPD.
“As a pulmonologist, I find Tiova (Tiotropium) to be an essential first-line maintenance therapy for many of my COPD patients. The 24-hour efficacy provides stable baseline control, and the Rotahaler, with proper training, is an effective delivery system. It’s a reliable agent in our arsenal against this progressive disease.” – Dr. A. Sharma, MD.